The AI-Driven Drug Discovery Summit aims to highlight the latest advancements in the application of AI for drug discovery. Over the course of two days, experts from the field will come together to:

• Explore how AI is enabling researchers to improve hit identification and lead generation through AI-enabled virtual screening of ultra-large chemical libraries; generative AI models for de novo drug design; and the designing and developing of digital twins for hit ID.
• Understand how recent advances in machine learning methods are improving the accuracy of therapeutic target identification.
• Connect with industry leaders using AI/ML to aid drug repositioning efforts and learn from SARS-CoV-2 drug repurposing efforts.

Healx’s Chief Scientific Officer, Dr Neil Thompson, will be delivering a speech on ‘AI-Powered Drug Repurposing for Rare Diseases’ (10:30, August 17^th).

We’re looking forward to what’s set to be an insightful session. Will we see you there? If you aren’t attending but would like to learn more about our work, please contact us for more information.